Stuart McLachlan
Corporate Officer/Principal chez Lypanosys Pte Ltd.
Postes actifs de Stuart McLachlan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Lypanosys Pte Ltd.
 Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Corporate Officer/Principal | 06/06/2011 | - |
Historique de carrière de Stuart McLachlan
Formation de Stuart McLachlan
| University of California, Davis | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 2 |
| Singapour | 2 |
Opérationnelle
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Lypanosys Pte Ltd.
Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Health Technology |
- Bourse
- Insiders
- Stuart McLachlan
- Expérience
